OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-SLC6A8 antibodies

Anti-SLC6A8 Antibody

div

Specifications Citations (0) Related Products Product Documents
SKU Description Amount Price Availability*  
TA314544 Rabbit polyclonal anti-SLC6A8 antibody 100ul $325 In Stock
Add to Shopping Cart

spacer
WB(1)

OriGene Data

ImmunogenThe antiserum was produced against synthesized peptide derived from C-terminal of human SLC6A8.
Clone Name IsotypeIgG
Species ReactivityHuman (Identities = 100%, Positives = 100%);Mouse (Identities = 100%, Positives = 100%);Rat (Identities = 100%, Positives = 100%) Concentration1mg/ml
Guaranteed Application *WB Suggested DilutionsWB: 1:500~1:3000, ELISA: 1:10000
BufferPhosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Note SLC6A8 antibody detects endogenous levels of total SLC6A8 protein.

Reference Data

Target NameHomo sapiens solute carrier family 6 (neurotransmitter transporter), member 8 (SLC6A8), transcript variant 2
Alternative NameCCDS1; CRT; CRTR; CT1; CTR5
Database LinkNP_001136277
Entrez Gene 6535 Human
Entrez Gene 102857 Mouse
Entrez Gene 50690 Rat
Function
Related PathwayTransmembraneDruggable Genome

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

Western blot analysis of extracts from HuvEc cells, using SLC6A8 antibody.The lane on the right is treated with the synthesized peptide.
spacer

 

spacer
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title